Article
Childhood Interstitial Lung Disease in Metabolic Disorders: Prevalence, Genotypic and Clinical Characteristics, and Management Approaches: An Analysis of the Child-Turkey Registry.
Pediatric pulmonology - 1 Apr 2026
Balcı Merve Selçuk, Zirek Fazılcan, Kekeç Handan, Hangül Melih, Öztürk Gökçen Kartal, Yavuz Burcu Çapraz, Bilgin Gülay, Özsezen Beste, Hızal Mina, Başkan Azer Kılıç, Özdemir Ali, Gürsoy Tuğba Ramaslı, Çobanoğlu Nazan, Eyüboğlu Tuğba Şişmanlar, Emiralioğlu Nagehan, Ceylan Ahmet Cevdet, Oğuz Berna, Orhan Diclehan, Kılınç Ayşe Ayzıt, Girit Saniye, Pekcan Sevgi, Cinel Güzin, Yalçın Ebru, Kiper Nural, Gökdemir Yasemin
Abstract excerpt
OBJECTIVE: Childhood interstitial lung disease (chILD) refers to a rare and heterogeneous group of disorders that can arise from genetic or acquired causes. Interstitial lung involvement due to metabolic diseases is a rare but significant condition among chILD cases. METHODS: This retrospective descriptive study analyzed data from the chILD-Turkey registry, established in November 2021, including patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
